Candidates Growth hormone production decreases at a rate of 14% per decade after the age of 35
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are effective for weight loss but cause gastrointestinal side effects, affecting adherence
Tirzepatide is a dual GIP/GLP-1 agonist that targets two incretin receptors simultaneously, producing more pronounced metabolic effects
En un ensayo clnico controlado, el 70 % de las mujeres mostraron una mejora en el colgeno de la piel despus del tratamiento de los muslos, en comparacin con el 50 % con vitamina C y el 40 % con cido retinoico
GLP-1 medications reverse many of these disruptions, which explains why they are now studied as potential tools to support ovulation, preconception health, and metabolic optimization before IVF
Charly Sturm is a long term member of Team Sturm and one of our regular Doctors Notes contributors